Delivery Order SPE2DB22D2206-SPE2DB25FJX03
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,657.94 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Prograf 1 mg capsules in quantities of 100 units. This contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without set-aside designation. The award represents a child contract under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $1,051.74 to supply 100 capsules of the 0.5 mg Prograf medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 21, 2023. No set-aside designation was applied to this order, which was awarded against an existing indefinite-delivery contract held by Amerisourcebergen...
- The Defense Logistics Agency awarded a $3,946.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the prescription medication Prograf in a 5 mg dosage. The delivery order was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 13-14, 2023. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- This is a $1,303.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, with a period of performance through May 30, 2025. The contract is not set aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FDU39, is for the delivery of Prograf 1 mg capsules to the Defense Logistics Agency (DLA). The $5,106.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, with no set-aside designation. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $9,173.56 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a performance period ending on May 8, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $2,460.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prograf 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical for $1,296.96. Under this contract vehicle, which provides pharmaceuticals and critical care supplies to support military treatment programs, Amerisourcebergen will deliver 100 capsules of the generic immunosuppressant drug tacrolimus (Prograf) to a DLA facility located...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJX03Delivery Order
The Defense Logistics Agency awarded a $1,393.41 delivery order to AmerisourceBergen Drug Corp for Prograf 5 mg/mL ampules, with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs for military and veteran healthcare systems, supplying an extensive range of pharmaceutical products and medical supplies. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, supporting the Defense Health Agency and other government healthcare systems through this flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/12/25 |